John M. Kane, MD

Article

Creating a Health Care Team to Manage Chronic Medical Illnesses in Patients With Severe Mental Illness: The Public Policy Perspective

June 25, 2009

John M. Kane

Original Research

Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics

April 21, 2009

John M. Kane, Wolfgang W. Fleischhacker, Lars Hansen, et al

Original Research

A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

March 24, 2009

John M. Kane, Olawale Osuntokun, Ludmila A. Kryzhanovskaya, et al

Article

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

March 4, 2009

Henry A. Nasrallah, Matcheri S. Keshavan, Francine M. Benes David, et al

Educational Activity

Sedation as a Side Effect of the Treatment of Mental Disorders

July 31, 2008

John M. Kane

Academic Highlights

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 2.

June 30, 2008

John M. Kane, Roy H. Perlis, Anil K. Malhotra

Article

An Evidence-Based Strategy for Remission in Schizophrenia

May 31, 2008

John M. Kane

Original Research

Identification of High-Risk Coronary Heart Disease Patients Receiving Atypical Antipsychotics: Single Low-Density Lipoprotein Cholesterol Threshold or Complex National Standard?

March 18, 2008

Christoph U. Correll, John M. Kane, Peter Manu

Educational Activity

Relapse Prevention in Patients With Schizophrenia

March 18, 2008

John M. Kane

Academic Highlights

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1

March 14, 2008

John M. Kane, Roy H. Perlis, Anil K. Malhotra

Article

Atypical Antipsychotics: Sedation Versus Efficacy

February 28, 2008

John M. Kane, Zafar A. Sharif

Original Research

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Design and Baseline Subject Characteristics

January 15, 2008

Brian L. Strom, Gerald A. Faich, Robert F. Reynolds, et al

Creating a Health Care Team to Manage Chronic Medical Illnesses in Patients With Severe Mental Illness: The Public Policy Perspective

Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics

A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Sedation as a Side Effect of the Treatment of Mental Disorders

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 2.

An Evidence-Based Strategy for Remission in Schizophrenia

Identification of High-Risk Coronary Heart Disease Patients Receiving Atypical Antipsychotics: Single Low-Density Lipoprotein Cholesterol Threshold or Complex National Standard?

Relapse Prevention in Patients With Schizophrenia

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1

Atypical Antipsychotics: Sedation Versus Efficacy

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Design and Baseline Subject Characteristics

ELSEWHERE:

FOLLOW US:

John M. Kane, MD

Creating a Health Care Team to Manage Chronic Medical Illnesses in Patients With Severe Mental Illness: The Public Policy Perspective

Akathisia: An Updated Review Focusing on Second-Generation Antipsychotics

A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Sedation as a Side Effect of the Treatment of Mental Disorders

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 2.

An Evidence-Based Strategy for Remission in Schizophrenia

Identification of High-Risk Coronary Heart Disease Patients Receiving Atypical Antipsychotics: Single Low-Density Lipoprotein Cholesterol Threshold or Complex National Standard?

Relapse Prevention in Patients With Schizophrenia

Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1

Atypical Antipsychotics: Sedation Versus Efficacy

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Design and Baseline Subject Characteristics

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles